Stay informed with the latest litigation news. Explore now

Breckenridge Pharmaceutical, Inc. V. Hetero Usa Inc. - 1:24-cv-00571

Explore the details of the Breckenridge Pharmaceutical, Inc. V. Hetero Usa Inc. case under case number 1:24-cv-00571 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00571
Filing Date
May 10, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Camber Pharmaceuticals, Inc. -
Hetero Labs Limited. -
Chad S.C. Stover -
Breckenridge Pharmaceutical, Inc. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Aug 9, 2024Pro Hac Vice Attorney Alexander Alfano, Ryan N. Kaiser, Adam C. LaRock for Camber Pharmaceuticals, Inc., Hetero Labs Limited Unit - III, Hetero Labs Limited., Hetero USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws)PACER Document
Aug 13, 2024SO ORDERED, re 17 MOTION for Pro Hac Vice Appearance of Attorney Christopher M. Gallo filed by Hetero Labs Limited Unit - III, Hetero Labs Limited., Hetero USA Inc., Camber Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 8/13/2024. (lnb)PACER Document
Aug 13, 2024Pro Hac Vice Attorney Christopher M. Gallo for Camber Pharmaceuticals, Inc., Hetero Labs Limited Unit - III, Hetero Labs Limited., Hetero USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd)PACER Document
Nov 6, 2024Reset Hearings: A Five-Day Jury Trial is set for 10/6/2026 -10/9/2026 and 10/13/2026 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. (lnb)PACER Document
Nov 6, 2024CORRECTING ENTRY: Reset Jury Trial dates due to correction. (lnb) Modified on 11/6/2024 (lnb).PACER Document
Nov 20, 2024SO ORDERED, re 33 STIPULATION TO EXTEND TIME to submit Proposed Protective Order to December 4, 2024 filed by Hetero Labs Limited Unit - III, Hetero Labs Limited., Hetero USA Inc., Camber Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 11/20/24. (jaa)PACER Document
Feb 10, 2025SO ORDERED, re 40 Stipulation filed by Breckenridge Pharmaceutical, Inc. Signed by Judge Gregory B. Williams on 2/10/2025. (lnb)PACER Document
Feb 21, 2025ORAL ORDER: Having reviewed the parties' joint letter requesting a discovery teleconference (D.I. 44), IT IS HEREBY ORDERED that, by no later than 5:00 p.m. on Tuesday, February 25, 2025, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute, its position on those issues, and supporting authority for its position(s). By no later than 5:00 p.m. on Thursday, February 27, 2025, any party opposing the request for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition and supporting authority. The parties shall provide the Court with two (2) courtesy paper copies of their respective letters with hard tabs inserted before any exhibits. If the Court determines that the dispute cannot be resolved based on the parties' letter submissions, the Court will schedule a discovery teleconference at a later date. ORDERED by Judge Gregory B. Williams on 2/21/2025. (lnb) (Entered: 02/21/2025)PACER Document
Feb 26, 2025CORRECTING ENTRY: Exhibit A-F in D.I. 50 have been replaced with the corrected PDF per counsel request. (jaa) Modified on 2/26/2025 (jaa).PACER Document
Mar 11, 2025ORAL ORDER: Having reviewed the parties' letter requesting a discovery teleconference (D.I. 59), IT IS HEREBY ORDERED that, by no later than 5:00 p.m. on Thursday, March 13, 2025, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute, its position on those issues, and supporting authority for its position(s). By no later than 5:00 p.m. on Monday, March 17, 2025, any party opposing the request for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition and supporting authority. The parties shall provide the Court with two (2) courtesy paper copies of their respective letters with hard tabs inserted before any exhibits. If the Court determines that the dispute cannot be resolved based on the parties' letter submissions, the Court will schedule a discovery teleconference at a later date. ORDERED by Judge Gregory B. Williams on 3/11/25. (jaa) (Entered: 03/11/2025)PACER Document
Mar 24, 2025SO ORDERED, re 65 STIPULATION TO EXTEND TIME and Order to submit a redacted version of D.I. 63 to March 21, 2025 filed by Breckenridge Pharmaceutical, Inc. Signed by Judge Gregory B. Williams on 3/24/25. (jaa)PACER Document
Apr 3, 2025ORAL ORDER: Having reviewed the parties' respective letter briefs (D.I. 63 and D.I. 64) concerning the pending discovery dispute raised by Plaintiff Breckenridge, the Court finds Defendants' responses to Plaintiff Breckenridge's Interrogatories Numbers 1, 2, 3, and 4 are deficient. Thus, the Court ORDERS that, on or before April 24, 2025, Defendants shall supplement their responses to Plaintiff Breckenridge's Interrogatories Numbers 1, 2, 3 and 4 by explaining the bases for Defendants' asserted counterclaims, as Defendants understood the bases as of the filing of the counterclaims on July 19, 2024. ORDERED by Judge Gregory B. Williams on 4/3/2025. (lnb) (Entered: 04/03/2025)PACER Document
Apr 28, 2025SO ORDERED, re 78 Stipulation filed by Breckenridge Pharmaceutical, Inc. Signed by Judge Gregory B. Williams on 4/28/2025. (lnb)PACER Document
May 15, 2025ORAL ORDER: Having reviewed and considered the parties' Joint Claim Construction Brief and other submissions related to today's claim construction hearing and the claim terms in dispute, the Court is reducing the time allotted for today's Markman hearing from three (3) hours to two (2) hours with the time to be divided evenly between the two sides. The hearing will still begin at 1:00 p.m. Signed by Judge Gregory B. Williams on 5/15/2025. (lnb) (Entered: 05/15/2025)PACER Document
May 15, 2025Minute Entry for proceedings held before Judge Gregory B. Williams - Markman Hearing held on 5/15/2025. Court Reporter M. Rolfe. (lnb)PACER Document
Jun 6, 2025SO ORDERED, re 88 STIPULATION TO EXTEND TIME the Substantial Completion of Document Production to July 9, 2025 filed by Breckenridge Pharmaceutical, Inc. Signed by Judge Gregory B. Williams on 6/6/2025. (lnb)PACER Document
Jun 12, 2025SO ORDERED, re 91 Proposed Order filed by Hetero Labs Limited Unit - III, Hetero Labs Limited., Hetero USA Inc., Camber Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 6/12/2025. (lnb)PACER Document
Jun 23, 2025ORAL ORDER: Having reviewed the parties' most recent request for a discovery teleconference (D.I. 92), IT IS HEREBY ORDERED that the Court will appoint a Special Master to resolve the current and all future discovery disputes in this action, with the costs of the Special Master to be split equally between the parties. ORDERED by Judge Gregory B. Williams on 6/23/2025. (lnb) (Entered: 06/23/2025)PACER Document
May 5, 2025JOINT CLAIM CONSTRUCTION BRIEF filed by Breckenridge Pharmaceutical, Inc.. (Attachments: # 1 Exhibit A-S)(Metzler, Sara) (Entered: 05/05/2025)Attachment